Xeroderma pigmentosum variant: response to etretinate

Br J Dermatol. 1990 Apr;122(4):559-61. doi: 10.1111/j.1365-2133.1990.tb14734.x.

Abstract

We report a case of the variant form of xeroderma pigmentosum in whom tumour development was completely suppressed for 22 months by etretinate 25 mg daily.

Publication types

  • Case Reports

MeSH terms

  • DNA Repair / physiology
  • Etretinate / administration & dosage
  • Etretinate / therapeutic use*
  • Humans
  • Male
  • Middle Aged
  • Skin Neoplasms / drug therapy*
  • Skin Neoplasms / genetics
  • Xeroderma Pigmentosum / drug therapy*
  • Xeroderma Pigmentosum / genetics

Substances

  • Etretinate